Question to the Ministry of Justice:

To ask the Secretary of State for Justice, if he will take steps to ensure that victims are (a) informed and (b) consulted about offenders who partake in chemical suppression programmes.

Medication to Manage Problematic Sexual Arousal (MMPSA) is a pharmaceutical intervention for offenders with ongoing clinical needs who may continue to pose a risk of harm to others because their sexual offending behaviour is driven by obsessive thoughts about sex and display compulsive sexual behaviour.

As MMPSA is a medication prescribed by clinicians according to the health needs of individuals, it would be inappropriate to share personal medical information on treatment with victims in accordance with medical confidentiality.

Eligible victims, including those of serious sexual offences, are supported through the Victim Contact Scheme where Victim Liaison Officers will offer tailored guidance, keep victims informed where appropriate, and help them navigate the parole process. Victims are entitled to measures such as being able to request a summary of a Parole Boards decision, and request additional conditions to an offender’s license in relation to themselves. These services are designed to ensure victims feel heard and supported, while also helping to maintain trust in the system.